Antiretroviral Therapy Adherence, Virologic and Immunologic Outcomes in Adolescents Compared With Adults in Southern Africa
Top Cited Papers
- 1 May 2009
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 51 (1), 65-71
- https://doi.org/10.1097/qai.0b013e318199072e
Abstract
Objective: To determine adherence to and effectiveness of antiretroviral therapy (ART) in adolescents vs. adults in southern Africa. Design: Observational cohort study. Setting: Aid for AIDS, a private sector disease management program in southern Africa. Subjects: Adolescents (age 11-19 years; n = 154) and adults (n = 7622) initiating ART between 1999 and 2006 and having a viral load measurement within 1 year after ART initiation. Main Outcome Measures: Primary: virologic suppression (HIV viral load ≤400 copies/mL), viral rebound, and CD4+ T-cell count at 6, 12, 18, and 24 months after ART initiation. Secondary: adherence assessed by pharmacy refills at 6, 12, and 24 months. Multivariate analyses: loglinear regression and Cox proportional hazards. Results: A significantly smaller proportion of adolescents achieved 100% adherence at each time point (adolescents: 20.7% at 6 months, 14.3% at 12 months, and 6.6% at 24 months; adults: 40.5%, 27.9%, and 20.6% at each time point, respectively; P < 0.01). Patients achieving 100% 12-month adherence were significantly more likely to exhibit virologic suppression at 12 months, regardless of age. However, adolescents achieving virologic suppression had significantly shorter time to viral rebound (adjusted hazard ratio 2.03; 95% confidence interval: 1.31 to 3.13; P < 0.003). Adolescents were less likely to experience long-term immunologic recovery despite initial CD4+ T-cell counts comparable to adults. Conclusions: Compared with adults, adolescents in southern Africa are less adherent to ART and have lower rates of virologic suppression and immunologic recovery and a higher rate of virologic rebound after initial suppression. Studies must determine specific barriers to adherence in this population and develop appropriate interventions.Keywords
This publication has 37 references indexed in Scilit:
- Long-Term Observation of Adolescents Initiating HAART Therapy: Three-Year Follow-UpAIDS Research and Human Retroviruses, 2007
- Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and FacilitatorsPLoS Medicine, 2006
- The Price of Adherence: Qualitative Findings From HIV Positive Individuals Purchasing Fixed-Dose Combination Generic HIV Antiretroviral Therapy in Kampala, UgandaAIDS and Behavior, 2006
- Enrolling Adolescents in Research on HIV and Other Sensitive Issues: Lessons from South AfricaPLoS Medicine, 2006
- Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1999
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in AdultsNew England Journal of Medicine, 1999
- Antiretroviral adherence issues among HIV-positive adolescents and young adultsJournal of Adolescent Health, 1999
- A Randomized, Controlled Trial of Indinavir, Zidovudine, and Lamivudine in Adults with Advanced Human Immunodeficiency Virus Type 1 Infection and Prior Antiretroviral TherapyThe Journal of Infectious Diseases, 1999
- A General Method of Compliance Assessment Using Centralized Pharmacy RecordsMedical Care, 1988
- Adolescents' compliance with therapeutic regimens: Psychological and social aspects and interventionJournal of Adolescent Health Care, 1987